123 related articles for article (PubMed ID: 33476628)
21. Multiple Functions of Fubp1 in Cell Cycle Progression and Cell Survival.
Kang M; Kim HJ; Kim TJ; Byun JS; Lee JH; Lee DH; Kim W; Kim DY
Cells; 2020 May; 9(6):. PubMed ID: 32481602
[TBL] [Abstract][Full Text] [Related]
22. B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis.
Li Y; Zhang J; Han S; Qian Q; Chen Q; Liu L; Zhang Y
Oncol Rep; 2017 Aug; 38(2):1043-1050. PubMed ID: 28627681
[TBL] [Abstract][Full Text] [Related]
23. Paip1 Indicated Poor Prognosis in Cervical Cancer and Promoted Cervical Carcinogenesis.
Li N; Piao J; Wang X; Kim KY; Bae JY; Ren X; Lin Z
Cancer Res Treat; 2019 Oct; 51(4):1653-1665. PubMed ID: 31010277
[TBL] [Abstract][Full Text] [Related]
24. Msi1 promotes tumor progression by epithelial-to-mesenchymal transition in cervical cancer.
Gong P; Wang Y; Gao Y; Gao M; Liu L; Qu P; Jin X; Gao Q
Hum Pathol; 2017 Jul; 65():53-61. PubMed ID: 28088346
[TBL] [Abstract][Full Text] [Related]
25. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
26. CircCDKN2B-AS1 interacts with IMP3 to stabilize hexokinase 2 mRNA and facilitate cervical squamous cell carcinoma aerobic glycolysis progression.
Zhang Y; Zhao L; Yang S; Cen Y; Zhu T; Wang L; Xia L; Liu Y; Zou J; Xu J; Li Y; Cheng X; Lu W; Wang X; Xie X
J Exp Clin Cancer Res; 2020 Dec; 39(1):281. PubMed ID: 33308298
[TBL] [Abstract][Full Text] [Related]
27. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin.
Cai S; Bai Y; Wang H; Zhao Z; Ding X; Zhang H; Zhang X; Liu Y; Jia Y; Li Y; Chen S; Zhou H; Liu H; Yang C; Sun T
J Exp Clin Cancer Res; 2020 Jul; 39(1):135. PubMed ID: 32669125
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-543 acts as a prognostic marker and promotes the cell proliferation in cervical cancer by BRCA1-interacting protein 1.
Dang H; Zheng P; Liu Y; Wu X; Wu X
Tumour Biol; 2017 Feb; 39(2):1010428317691187. PubMed ID: 28231728
[TBL] [Abstract][Full Text] [Related]
30. Synaptonemal complex protein 3 is a prognostic marker in cervical cancer.
Cho H; Noh KH; Chung JY; Takikita M; Chung EJ; Kim BW; Hewitt SM; Kim TW; Kim JH
PLoS One; 2014; 9(6):e98712. PubMed ID: 24905095
[TBL] [Abstract][Full Text] [Related]
31. Far upstream element-binding protein 1 (FUBP1) is a potential c-Myc regulator in esophageal squamous cell carcinoma (ESCC) and its expression promotes ESCC progression.
Yang L; Zhu JY; Zhang JG; Bao BJ; Guan CQ; Yang XJ; Liu YH; Huang YJ; Ni RZ; Ji LL
Tumour Biol; 2016 Mar; 37(3):4115-26. PubMed ID: 26490982
[TBL] [Abstract][Full Text] [Related]
32. Low expression of NCOA5 predicts poor prognosis in human cervical cancer and promotes proliferation, migration, and invasion of cervical cancer cell lines by regulating notch3 signaling pathway.
Liang Y; Zhang T; Shi M; Zhang S; Guo Y; Gao J; Yang X
J Cell Biochem; 2019 Apr; 120(4):6237-6249. PubMed ID: 30335900
[TBL] [Abstract][Full Text] [Related]
33. Blocking Modification of Eukaryotic Initiation 5A2 Antagonizes Cervical Carcinoma via Inhibition of RhoA/ROCK Signal Transduction Pathway.
Liu X; Chen D; Liu J; Chu Z; Liu D
Technol Cancer Res Treat; 2017 Oct; 16(5):630-638. PubMed ID: 27609633
[TBL] [Abstract][Full Text] [Related]
34. Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.
Wang R; Li Y; Du P; Zhang X; Li X; Cheng G
Life Sci; 2019 Sep; 233():116708. PubMed ID: 31369759
[TBL] [Abstract][Full Text] [Related]
35. MiR-16-1 Targeted Silences Far Upstream Element Binding Protein 1 to Advance the Chemosensitivity to Adriamycin in Gastric Cancer.
Zhao D; Zhang Y; Song L
Pathol Oncol Res; 2018 Jul; 24(3):483-488. PubMed ID: 28667493
[TBL] [Abstract][Full Text] [Related]
36. microRNA-802 inhibits cell proliferation and induces apoptosis in human cervical cancer by targeting serine/arginine-rich splicing factor 9.
Zhang Q; Lv R; Guo W; Li X
J Cell Biochem; 2019 Jun; 120(6):10370-10379. PubMed ID: 30565744
[TBL] [Abstract][Full Text] [Related]
37. Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target of cervical cancer.
Wang J; Wang Y; Shen F; Xu Y; Zhang Y; Zou X; Zhou J; Chen Y
Cancer Med; 2018 Nov; 7(11):5665-5678. PubMed ID: 30334367
[TBL] [Abstract][Full Text] [Related]
38. RIP1 upregulation promoted tumor progression by activating AKT/Bcl-2/BAX signaling and predicted poor postsurgical prognosis in HCC.
Wang C; Yao B; Xu M; Zheng X
Tumour Biol; 2016 Nov; 37(11):15305-15313. PubMed ID: 27699664
[TBL] [Abstract][Full Text] [Related]
39. Lipid metabolism regulator human hydroxysteroid dehydrogenase-like 2 (HSDL2) modulates cervical cancer cell proliferation and metastasis.
Yang Y; Han A; Wang X; Yin X; Cui M; Lin Z
J Cell Mol Med; 2021 May; 25(10):4846-4859. PubMed ID: 33738911
[TBL] [Abstract][Full Text] [Related]
40. miR-587 promotes cervical cancer by repressing interferon regulatory factor 6.
Ren Y; Dong J; He P; Liang Y; Wu L; Wang J; Chu B
J Gene Med; 2020 Nov; 22(11):e3257. PubMed ID: 32749750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
